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Abstract
OBJECTIVES: Inherent technical aspects of pulmonary lobectomy by video-assisted thoracoscopic surgery (VATS) may limit surgeons’
ability to deal with factors predisposing to complications. We analysed complication rates after VATS lobectomy in a prospectively
maintained nationwide registry.
METHODS: The registry was queried for all consecutive VATS lobectomy procedures from 49 Italian Thoracic Units. Baseline condition, tu-
mour features, surgical techniques, devices, postoperative care, complications, conversions and the reasons thereof were detailed.
Univariable and multivariable regressions were used to assess factors potentially linked to complications.
RESULTS: Four thousand one hundred and ninety-one VATS lobectomies in 4156 patients (2480 men, 1676 women) were analysed. The
median age-adjusted Charlson index of the patients was 4 (interquartile range 3–6). Grade 1 and 2 and Grade 3–5 complications were
observed in 20.1% and in 5.8%, respectively. Ninety-day mortality was 0.55%. The overall conversion rate was 9.2% and significantly higher
in low-volume centres (<100 cases, P < 0.001), but there was no significant difference between intermediate- and high-volume centres
under this aspect. Low-volume centres were significantly more likely to convert due to issues with difficult local anatomy, but not signifi-
cantly so for bleeding. Conversion, lower case-volume, comorbidity burden, male gender, adhesions, blood loss, operative time, sealants
and epidural analgesia were significantly associated with increased postoperative morbidity.
CONCLUSIONS: VATS lobectomy is a safe procedure even in medically compromised patients. An improved classification system for con-
versions was proposed and prevention strategies were suggested to reduce conversion rates and possibly complications in less-
experienced centres.
Keywords: Video-assisted thoracoscopic surgery lobectomy • Morbidity • Conversion • Postoperative complications
INTRODUCTION
Video-assisted thoracoscopic surgery (VATS) has been increasing-
ly adopted for the management of resectable lung cancer in the
last 2 decades. Despite a large body of literature indicating that
VATS lobectomy may be safer, better tolerated and at least
equivalent to open surgery from an oncological standpoint [1–6],
some inherent aspects of VATS surgery, e.g. absence of direct
tactile sensation, limited room and freedom of movement of in-
strumentation, loss of 3-dimensional vision, may limit surgeons’
ability to deal safely with local factors that predispose to intrao-
perative accidents, such as hilar calcification and abnormal anat-
omy, or may lead to inadequate oncological results, such as
poorly defined tumour margins and fissure involvement.
In late 2013, the Italian Society of Thoracic Surgery invited
thoracic units in Italy to contribute to a nationwide registry (the
Italian VATS Group database), on a voluntary basis and without
compensation. The registry has since prospectively collected
detailed information on clinical characteristics, patterns of surgi-
cal care and outcomes of patients receiving VATS lobectomy. To
explore which factors may be most important in determining
perioperative adverse events in this setting, we analysed compli-
cation rates of VATS lobectomy in the Italian VATS Group data-
base in relation to patient characteristics, surgical technique,
devices and disease features.
MATERIALS AND METHODS
The VATS Group database (the registry) was queried to extract
detailed information on all VATS lobectomy procedures
(including those that were eventually converted to an open
lobectomy) carried out consecutively in all thoracic units that
had contributed to the registry between 1 January 2014 and 30
June 2017, for the purpose of an intention-to-treat analysis.
Patient information in the registry included the following:
centre and patient codes, demographic data and baseline
performance status, oncological history, and lung function
testing, comorbidities and comorbidity burden synthesized by
the age-adjusted Charlson comorbidity index (CCI); details
from imaging studies, bronchoscopy, mediastinal staging and
preoperative biopsy; detailed information on surgical technique,
stapling and energy devices, type of lymph node dissection and
number of N1 and N2 nodes harvested, pathology, use of seal-
ants, operative time and blood loss, size and number of chest
drains and type of water seal employed.
A conversion was defined as an unplanned thoracotomy for
any reason during the VATS operation, whereas the reasons for
conversion were recorded in a structured fashion.
Short-term outcome data included days with drainage, length
of postoperative stay and daily numeric rating scale pain assess-
ments. Perioperative adverse events were reported according to
the Thoracic Morbidity and Mortality (TM&M) System [7].
Follow-up data were required to be entered every 6 months.
For this study, the preoperative stage was obtained by
combining all data from chest computed tomography (CT) and
18-fluorodeoxyglucose positron emission tomography (PET)
studies, endoscopy and invasive staging T1–2, N0, M0 tumours
were defined as early-stage, while T3–4 and/or N1–N2 tumours
as locally advanced disease, and postoperative complications
were classified as minor to mild (Grade 1 and 2) or major (Grade
3–5).
The number of surgeons performing VATS lobectomies in each
centre was obtained from a survey circulated to participating
units in mid-2017.
Approval from the ethics committee was obtained, and patient
and centre information was anonymized before data extraction
and analysis.
Statistical analysis
Patient data are presented as number and percentages, mean
and standard deviation or median and interquartile range (IQR)
as appropriate. For proportion comparisons between groups, the
v2 test was used, or the Fisher’s exact test when necessary, and
the conservative Bonferroni adjustment for P-values. Patient-
related factors, procedural and technical variables and tumour
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data were analysed by scatterplots, and univariable logistic re-
gression models to explore their association with the risk of
developing postoperative complications. Independent variables
potentially linked to postoperative complications were included
in the full generalized linear mixed model with binomial response
and centre as a random effect to model the probability of com-
plications following VATS lobectomy. Model-building strategies
included checking of convergence and goodness-of-fit test. The
Akaike information criterion was used to compare candidate
models.
A statistical significance level of 0.05 was adopted for all tests.
All statistical analyses were carried out both in the R and SAS
software.
RESULTS
This data set consists of 4191 VATS lobectomy procedures car-
ried out by 49 specialized thoracic units on 4156 patients: 2480
men and 1676 women). The median age was 69 (IQR 64–75)
years for men and 67 (IQR 59–73) years for women.
Multiple comorbidities were frequent in these patients, and
the median age-adjusted CCI was 4 (IQR 3–6) for the whole group.
Chronic obstructive pulmonary disease (19.5%) and cardiovascular
disorders (26.1%) were the most prevalent Charlson items, whereas
all other items had an individual prevalence of <4%.
A preoperative PET scan was available before the procedure in
91% of the cases. Preoperative mediastinal staging by endobron-
chial ultrasound examination (EBUS) was reported in 3.4% and
by mediastinoscopy in 1%.
An anterior 3-portal approach was the most widely employed
(69% of the procedures), 2 ports were used in 15% and uniportal
VATS lobectomy was performed in 8% of the cases. In the
remaining 8% of cases, more than 3 ports were used.
Patient-related, tumour-related and procedural variables sig-
nificantly linked to perioperative outcomes are summarized in
Table 1.
Minor to mild and major complications were observed in
20.1% and in 5.8% of the cases, respectively.
The majority of adverse events consisted in air leaks beyond
postoperative day 7 (36.9%), cardiovascular events (31.1%), re-
spiratory complications (22.7%) and postoperative bleeding
(12.6%). Major adverse events consisted mostly in pleuropulmo-
nary complications (142 patients, 13.1%) and postoperative
bleeding (3.4%). Follow-up data were available for 3485 patients
(84%). Thirty-day mortality was 8 out of 3485 (0.23%, 95% CI
0.10–0.45) patients, and 90-day mortality was 19 out of 3485
(0.55%, 95% CI 0.33–0.85) patients.
Conversion rates to unplanned thoracotomy and the reasons
for conversion are shown in Table 2.
Low-volume centres were significantly more likely to convert
due to issues with difficult anatomy (unrelated to tumour inva-
sion) and slightly more likely to convert for vascular lesions than
intermediate- and high-volume centres.
All factors independently related to perioperative complica-
tions at multivariable analysis are summarized in Table 3. Among
them, lower case-volume and conversion were independently
associated with a greater risk of complications of any grade after
correcting for confounders.
Factors that were not significant either at univariable analysis
or after correcting for confounders are summarized in
Supplementary Material, Tables S1 and S2.
These include induction chemotherapy, the number of surgical
incisions, mediastinal nodal dissection, R1 resection, preoperative
pathological diagnosis, pre- and post-treatment tumour stage,
number of chest drains, smaller-bore (<_24 Fr) chest tubes and the
use of energy devices. However, energy devices were associated
with a modest, statistically significant reduction in operative time
(median 169.5 min, IQR 140–200 vs 180 min, IQR 140–220,
P = 0.0003).
There was a trend towards an increased complication rate with
the number of mediastinal N2 nodes removed, but the associ-
ation did not reach statistical significance (P = 0.056).
Table 1: Variables significantly associated with postoperative
complications
Complications None (%) Any (%) G3–G5 (%)a All (%)
All procedures 3108 (74) 1083 (26) 241 (22) 4191 (100)
Male sex 1749 (70) 745 (30) 172 (23) 2494 (60)
CCI 4+ 2023 (71) 842 (29) 191 (23) 2865 (68)
Mean age ± SD 67 ± 9.6 69 ± 8.8 69 ± 9.8 67 ± 9.7
Mean %ppoFEV1b ± SD 75 ± 16.9 70 ± 16.6 68 ± 15.0 69 ± 16.7
Centre volume (cases)
1–100 1116 (70) 471 (30) 96 (20) 1587 (38)
101–200 1010 (74) 363 (26) 93 (26) 1373 (33)
>200 982 (80) 249 (20) 52 (21) 1231 (29)
Procedure (lobe)
RUL 1008 (72) 400 (28) 102 (26) 1408 (34)
LLL 611 (81) 145 (19) 20 (14) 756 (18)
RML 274 (85) 48 (15) 9 (19) 322 (8)
Wound retractors
No 1642 (73) 596 (27) 137 (23) 2238 (53)
Yes 1466 (75) 487 (25) 104 (21) 1953 (47)
Pleural adhesions
No 2572 (77) 783 (23) 150 (19) 3355 (80)
Yes 536 (64) 300 (36) 91 (30) 836 (20)
Use of sealants
No 2204 (77) 675 (23) 144 (21) 2879 (69)
Yes 904 (69) 408 (31) 97 (24) 1312 (31)
Pain management
IV only 538 (75) 181 (25) 31 (17) 719 (17)
IV + intercostal block 1864 (76) 577 (24) 138 (24) 2441 (58)
IV + epidural 706 (69) 325 (32) 72 (22) 1031 (25)
Operative time (min),
median (IQR)c
175 (70) 190 (90) 204 (84)
Blood loss (mL)
<_100 1777 (78) 511 (22) 76 (15) 2288 (55)
101–200 1034 (74) 367 (26) 85 (23) 1401 (33)
200+ 297 (59) 205 (21) 50 (24) 502 (12)
Conversion
No 2881 (76) 924 (24) 196 (21) 3805 (91)
Yes 227 (59) 159 (41) 45 (28) 386 (9)
Bronchoscopy
Negative 1449 (75) 483 (25) 101 (21) 1932 (46)
Positive 302 (67) 151 (33) 41 (27) 453 (11)
Unspecified 1357 (75) 449 (25) 99 (22) 1806 (43)
Pathology
Adenocarcinoma 2034 (75) 691 (25) 139 (20) 2725 (65)
Squamous 408 (66) 208 (34) 62 (30) 616 (15)
Carcinoid 232 (85) 41 (15) 9 (22) 273 (7)
Other 328 (74) 117 (26) 6 (5) 445 (10)
Non-neoplastic 106 (80) 26 (20) 7 (27) 132 (4)
aPercentage of G3 or worse complications on total number complications.
bPercent-predicted postoperative forced expiratory volume in 1 second.
cPercentages may not add up to 100 because of rounding.
CCI: age-adjusted Charlson comorbidity index; FEV1: forced expiratory
volume in 1 second; IV: intravenous infusion; LLL: left lower lobectomy;
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DISCUSSION
This analysis of a large series from a network of specialized Italian
thoracic units with variable levels of expertise showed the overall
morbidity rate after VATS lobectomy to be 26%, with major
complications occurring after 5.8% of the procedures.
The overall conversion rate was 9.2%. Low-volume centres had
an increased rate of conversion and complications compared
with the intermediate-volume centre and the high-volume centre
(Table 2). As a surgeon may convert electively to avoid getting
into trouble, conversion was not considered as a complication in
itself, in this analysis.
For a more in-depth investigation into the reasons for conver-
sion to thoracotomy, we used a modified classification, similar to
the already proposed VALT system [8] that discriminates between
tumour extension and fibrous adhesions. Issues with difficult
local anatomy, such as a fused fissure, adhesions, calcified hilar
nodes or unclear anatomy, led most commonly to conversion
across all levels of expertise, but more so in centres that had per-
formed <100 VATS lobectomies, without clear differences be-
tween centres that had performed 101–200 or over 200 cases.
Conversions due to vascular lesions, unclear anatomy and
technical issues related to the learning curve effect were also
more frequent in high-volume centres; however, numbers were
too small to reach statistical significance.
Other authors have also previously reported similar factors as
predictors of unplanned thoracotomy [9–12], and that conversion
rates were lower in highly experienced centres. Nonetheless,
serious intraoperative complications may occur at any level of
expertise, possibly due to a greater propensity of experienced
surgeons to tackle more difficult cases by VATS [13].
However, in our series and in contrast with previous reports
[14], unplanned thoracotomy was also independently associated
with an increased risk of postoperative complications.
This observation is in agreement with Puri et al. [9] who
observed overall complication and 30-day mortality rates of 23%
and 0%, respectively in 517 successful VATS lobectomies, com-
pared to 46% and 1.1% in 87 procedures converted to thoracot-
omy and 42% and 0.8% in 623 planned open lobectomies carried
out in the same period of time in their institution.
The median age-adjusted CCI in our population was 4 (IQR 3–6)
indicating a substantial comorbidity burden, which in turn carries a
higher risk of complications of any grade (Table 1). However, des-
pite one-third of the cases having been operated upon in centres
with previous experience of <100 cases, postoperative morbidity
and mortality in the VATS Group database compare well with the
most recent VATS lobectomy series where morbidity rates vary
around 25–35% and 30-day mortality is typically around 1% [1–6].
We hypothesize that participation in a nationwide registry
encourages all centres to adopt internal protocols that may con-
tribute to improving perioperative outcomes. The impact of male
gender on the risk of postoperative complications has been con-
sistently reported [3, 4, 12], and may possibly be related to higher
smoking exposure (not captured in the database) or to gender-
related biological differences yet to be elucidated.
The low percentage of invasive mediastinal staging is most
likely due to case selection, as not many centres routinely per-
form EBUS preoperatively and rely on PET scan for mediastinal
assessment.
In addition, a positive mediastinal biopsy would likely prompt
the administration of induction chemotherapy, and not many
surgeons performed VATS lobectomy after induction, as shown
by the relatively small number of patients receiving neoadjuvant
treatment in this series.
As the registry collects detailed information on all technical
aspects of VATS lobectomy, a great number of variables could be
tested in the statistical model (Table 3 and Supplementary
Material Tables S1 and S2).
Table 2: Causes of conversion to unplanned thoracotomy
Centre volume Low (1–100) Intermediate (101–200) High (>200) All P-value
Number of procedures, N (%) 1587 (38) 1373 (33) 1231 (29) 4191 (100)
Number of centres, N (%) 35 (71) 10 (20) 4 (9) 49 (100)
Number of cases per month, median (range) 1.2 (0.2–2.4) 2.9 (2.5–4.4) 7.1 (5.8–9.3)
Number of surgeons 1–6 2–5 3–5
Conversion 187 (11.8) 103 (7.5) 95 (7.7) 386 (9.2) <0.001a
Anatomical issues 105 (6.6) 47 (3.4) 47 (3.8) 199 (4.7) <0.001b
Adhesions 32 (2.0) 21 (1.5) 12 (1.0) 65 (1.6) 0.085b
Hilar calcification 32 (2.0) 10 (0.7) 21 (1.7) 63 (1.5) 0.013b
Fused fissure 28 (1.8) 6 (0.4) 9 (0.7) 43 (1.0) <0.001b
Unclear anatomy 13 (0.8) 10 (0.7) 5 (0.4) 28 (0.7) 0.39
Vascular (bleeding) 52 (3.3) 35 (2.5) 35 (2.8) 122 (2.9) 0.49
Technical (learning) 11 (0.7) 2 (0.1) 4 (0.3) 17 (0.4) 0.10c
Time constraints 2 (0.1) (0.0) (0.0) 2 (0.0)
Lesion not found 8 (0.5) 2 (0.1) 4 (0.3) 14 (0.3) 0.24c
Multiple (not bleeding) 1 (0.1) (0.0) (0.0) 1 (0.0)
Tumour extension 13 (0.8) 15 (1.1) 8 (0.6) 36 (0.9) 0.46b
Close to hilum 7 (0.4) 10 (0.7) 5 (0.4) 22 (0.5) 0.44c
Invading fissure 6 (0.4) 5 (0.4) 3 (0.2) 14 (0.3) 0.53c
Unspecified cause 6 (0.4) 4 (0.3) 1 (0.1) 11 (0.3) 0.35c
Percentages refer to the number of procedures in each subgroup. Fused fissure: low-volume centres differ from intermediate- (adjusted P = 0.002) and high-vol-
ume centres (adjusted P = 0.0506); Hilar calcification: low-volume centres differ from intermediate-volume (adjusted P = 0.009); anatomy: low-volume centres dif-
fer from intermediate- (adjusted P < 0.001) and high-volume centres (adjusted P = 0.003).
aLow-volume centres differ from intermediate-(adjusted P < 0.001) and high-volume centres (adjusted P <_ 0.001).
bThe v2 test.
cThe Fisher’s exact test.
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No significant difference in postoperative morbidity rates was
observed in relation to the number of surgical ports, suggesting
that uniportal or biportal approaches are comparable to the clas-
sic 3-portal anterior approach with respect to postoperative
morbidity.
Systematic lymphadenectomy and the number of N1 and N2
lymph nodes harvested were similarly not linked with higher
morbidity rates, a finding that supports the notion that hilar
nodal dissection can be performed adequately and safely by
VATS [15–17].
Additionally, we could not find any significant difference
in complication rates with the use of 1 vs 2 chest drains, or
with a large bore (28–32 Fr.) versus smaller bore chest
tubes.
Table 3: Multivariate analysis
Postoperative complications
Any grade G3–G5
Univariable Multivariable Univariable Multivariable
P-value OR 95% CI P-value P-value OR 95% CI P-value
Gender
Female 1
Male <0.001 1.404 1.201–1.641 <0.001 <0.001
CCI
0–3 1 1
4 0.004 1.296 1.051–1.599 0.015 0.38
5–6 <0.001 1.728 1.428–2.091 <0.001 <0.001 1.622 1.123–2.341 0.011
7+ <0.001 2.467 1.943–3.131 <0.001 <0.001 2.074 1.352–3.181 0.001








>200 <0.001 0.693 0.554–0.868 <0.001 0.033
Procedure (lobe)
RUL 1 1
LLL <0.001 0.608 0.486–0.761 <0.001 <0.001 0.348 0.212–0.572 <0.001
RML <0.001 0.532 0.379–0.748 <0.001 0.006 0.438 0.213–0.900 0.029
Operative time (minutes)
<_140 1 1
140–180 0.38 0.38 1.034
180–220 0.001 0.002 1.548 1.001–2.393 0.049
220–540 <0.001 1.343 1.069–1.687 0.011 <0.001 1.781 1.171–2.707 0.007
Conversion
No 1 1
Yes <0.001 1.429 1.118–1.826 0.004 <0.001 1.676 1.153–2.436 0.007
Wound retractors
No 1 1
Yes 0.21 0.772 0.658–0.906 0.002 0.27 0.723 0.545–0.958 0.024
Pleural adhesions
No 1 1
Yes <0.001 1.422 1.192–1.696 <0.001 <0.001 1.959 1.46–2.616 <0.001
Sealants
No 1 1
Yes <0.001 1.199 1.020–1.408 0.027 0.002
Pain control
I.V. only 1 1
Intercostal block 0.38 0.14
Epidural 0.003 1.384 1.103–1.736 0.005 0.002 1.875 1.191–2.953 0.007
Bronchoscopy
Negative 1 1
Positive <0.001 1.394 1.095–1.775 0.007 0.002 1.722 1.155–2.567 0.008
Pathology
Adenocarcinoma 1 1




CCI: age-adjusted Charlson comorbidity index; CI: confidence interval; I.V.: intravenous infusion; LLL: left lower lobectomy; OR: odds ratio; ppoFEV1: percent-pre-
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On the contrary, soft-tissue retractors were associated with a
reduced risk of complications. We hypothesize that their use
might reduce the need for repeated camera cleansing causing
less fatigue and stress within the surgical team.
Energy devices were not associated with an increased or
reduced risk of complications, but their use saves some time and
effort, therefore, surgeons can elect to make use of them or not,
depending on time constraints and financial considerations [18].
The use of sealants was instead associated with a higher prob-
ability of complications in this series, which may be due to a ‘se-
lection by indication’ bias, i.e. their preferential use in patients
who are intraoperatively perceived to be at higher risk, such as
after a difficult dissection, or those with emphysematous lungs
(data not captured in the registry).
Epidural analgesia was also associated with an increased post-
operative complication rate in this analysis. Once again, a selec-
tion bias may be present. Nonetheless, it is also possible that
procedural morbidity of epidural analgesia (albeit generally mild)
may surpass its expected benefits after a relatively less painful,
minimally invasive procedure [19, 20]. Further investigation is
warranted on this important aspect of postoperative care after
VATS lobectomy.
Limitations
The main limitations of this study lie in its retrospective nature
and absence of a control arm; exclusion of open lobectomies
from the registry precludes any comparison with traditional sur-
gery. Moreover, the database does not capture information on
case-volume per single surgeon. As caseload may be unevenly
distributed within a unit, these data may not accurately reflect
the effect of case-volume. However, low-volume surgeons in an
intermediate- or high-volume unit may benefit from obtaining
support from experienced staff. Additionally, Birkmeyer et al. [21]
showed that surgeon volume is a relatively less powerful deter-
miner of perioperative mortality after pulmonary lobectomy
compared with other surgical cancer procedures. By extrapola-
tion, centre case-volume may be more relevant than individual
caseload in relation to perioperative outcomes, due to a system
effect.
The plus points of this study are that a large amount of data
was available from a large series of cases on virtually all aspects
of VATS lobectomy. Information on the baseline status was care-
fully collected in a prospective fashion and used to construct the
age-adjusted CCI, a reproducible and validated measure inde-
pendently linked to short and long-term outcomes in lung cancer
patients [22]. And postoperative morbidity data were collected
and classified according to the comprehensive and reproducible
thoracic morbidity and mortality system, based on the entity of
the countermeasures taken to restore the patient’s clinical course
towards normal [7, 23].
Comparisons of early postoperative outcomes among surgical
patient cohorts are, in fact, hampered by a lack of standards in
reporting on baseline status and postoperative morbidity, with
several classifications adopted in the literature [4, 24].
Such variability can have consequences in the interpretation of
data: in 2 recent studies [25, 26], 45–62% of major cardiopulmon-
ary complications according to the ESTS classification were
reclassified as minor ones by the TM&M system, and in such
cases the postoperative course and length of stay were signifi-
cantly shorter than in those that remained ‘severe’ by
both systems. The TM&M classification may, therefore, allow a
better estimate of the financial impact of postoperative compli-
cations [27].
CONCLUSIONS
In conclusion, this analysis supports the notion that VATS lobec-
tomy can be considered a relatively safe procedure even in com-
promised patients.
Conversion to unplanned thoracotomy leads to an increased
risk of postoperative complications and a case-volume of 100
procedures at least, carried out in a centre during the observa-
tion period was associated with lower conversion rates and
reduced postoperative complications.
An improved classification system for conversions is proposed,
based on which it is suggested that a systematic preoperative
assessment of the local anatomy based on 3-dimensional-CT
reconstructions [28] or even 3-dimensional-printed models [29]
should be investigated as a strategy to reduce operating time,
conversions and possibly complication rates after VATS
lobectomy.
SUPPLEMENTARY MATERIAL
Supplementary material is available at EJCTS online.
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